Cargando…

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay

Antibodies to neuraminidase (NA), the second most abundant surface protein on influenza virus, contribute toward protection against influenza. Traditional methods to measure NA inhibiting (NI) antibody titers are not practical for routine serology. This protocol describes the enzyme-linked lectin as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jin, Couzens, Laura, Eichelberger, Maryna C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MyJove Corporation 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091984/ https://www.ncbi.nlm.nih.gov/pubmed/27684188 http://dx.doi.org/10.3791/54573

Ejemplares similares

Use of lentiviral pseudotypes as an alternative to reassortant or Triton X‐100‐treated wild‐type Influenza viruses in the neuraminidase inhibition enzyme‐linked lectin assay
por: Biuso, Fabrizio, et al.
Publicado: (2019)

A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigens
por: Sandbulte, Matthew R., et al.
Publicado: (2009)

An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies
por: Prevato, Marua, et al.
Publicado: (2015)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study
por: Bernard, Marie-Clotilde, et al.
Publicado: (2022)

Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay
por: Prevato, Marua, et al.
Publicado: (2015)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
por: Rajendran, Madhusudan, et al.
Publicado: (2017)

Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
por: Eichelberger, Maryna C, et al.
Publicado: (2008)

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
por: Wan, Hongquan, et al.
Publicado: (2015)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines
por: Getie‐Kebtie, Melkamu, et al.
Publicado: (2012)

Neutralizing and Neuraminidase Antibodies Correlate With Protection Against Influenza During a Late Season A/H3N2 Outbreak Among Unvaccinated Military Recruits
por: Weiss, Carol D, et al.
Publicado: (2019)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors
por: Kožíšek, Milan, et al.
Publicado: (2018)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Creytens, Sarah, et al.
Publicado: (2021)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Krammer, Florian, et al.
Publicado: (2018)

Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses
por: Orange, Jordan S., et al.
Publicado: (2015)

Comparability of Titers of Antibodies against Seasonal Influenza Virus Strains as Determined by Hemagglutination Inhibition and Microneutralization Assays
por: Heeringa, Marten, et al.
Publicado: (2020)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
por: Waerlop, Gwenn, et al.
Publicado: (2022)

Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets
por: Tingstedt, Jeanette Linnea, et al.
Publicado: (2023)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
por: Momont, Corey, et al.
Publicado: (2023)

Real Time Enzyme Inhibition Assays Provide Insights into Differences in Binding of Neuraminidase Inhibitors to Wild Type and Mutant Influenza Viruses
por: Barrett, Susan, et al.
Publicado: (2011)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response
por: Changsom, Don, et al.
Publicado: (2016)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

An enzyme-linked immunosorbent assay (ELISA) for measurement of heterophile antibody.
por: Hsu, J. F., et al.
Publicado: (1982)

Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection
por: Zhou, Fan, et al.
Publicado: (2021)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
por: Skarlupka, Amanda L., et al.
Publicado: (2021)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients
por: Palmer, John, et al.
Publicado: (2017)

Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies
por: Kosik, Ivan, et al.
Publicado: (2019)

Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry
por: Momont, Corey, et al.
Publicado: (2023)

Australian Aboriginal Children with Otitis Media Have Reduced Antibody Titers to Specific Nontypeable Haemophilus influenzae Vaccine Antigens
por: Thornton, Ruth B., et al.
Publicado: (2017)

Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2
por: Bien, Christian G.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4i7hibuq3jnl15qksqp1ec0gq4